Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Gnosall Limited investment portfolio

Gnosall Limited has made numerous investments in companies such as Hone Bio, Carbometrics, and Halo Therapeutics within the Healthcare & Life Sciences sector.

unknown
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Carbometrics Limited
Carbometrics designs and synthesises highly selective synthetic glucose‑binding molecules that enable ultra‑accurate continuous metabolic monitoring, and applies this technology in products such as i‑CAM, a comprehensive metabolic monitor for cardiopulmonary bypass and organ‑perfusion circuits, aimed at healthcare providers and medical‑device manufacturers.
Healthcare & Life SciencesBristolConfirmed2025-07-02
Halo Therapeutics LtdHealthcare & Life SciencesCaerphillyConfirmed2025-10-30

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (4)

Gnosall Limited's positions across portfolio companies
2026
2024
  • 11-21IncreasedHone Bio Limited
    • B ORDINARY 1,429 → 14,290
    • B-1 ORDINARY 0 → 5,350

Sign up free to see when this investor has bought or sold shares.

+2 more changes

Sign up